Oct 4 (Reuters) - Bioretec Oy BRETEC.HE :
* INSIDE INFORMATION: BIORETEC UPDATES ITS FINANCIAL TARGETS
* NEW FINANCIAL TARGET: REACH NET SALES OF EUR 65 MILLION BY
END
OF YEAR 2028
* TARGET TO REACH POSITIVE CASH FLOW FROM OPERATING
ACTIVITIES BY
END OF YEAR 2027 (PREVIOUS TARGET: BY END OF YEAR 2026)
* PREVIOUSLY COMMUNICATED TARGET CHANGED DUE TO DELAY IN
RECEIVING
MARKET AUTHORIZATION OF REMEOS™ TRAUMA SCREW IN EUROPE
* TARGET TO REACH NET SALES IN EXCESS OF EUR 100 MILLION BY
END OF
YEAR 2030
* PREVIOUS NET SALES TARGET: EUR 62 MILLION BY END OF YEAR
2027
Source text for Eikon: ID:nWkr1D1K39
Further company coverage: BRETEC.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))